Pharma’s supplier sprawl problem: When more vendors create less control
Many pharmaceutical companies have steadily accumulated logistics partners as each product launch, market entry or acquisition added another provider into…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Oral solid dose at a turning point: Scaling for the next generation of therapies
As the first oral GLP-1 receptor agonists launch in 2026, we are reminded yet again of the enduring importance of…
-
The rare disease revolution: The state of play for CGTs in orphan diseases
Rare diseases are chronic conditions that affect between 3.5% and 5.9% of the global population. About 80% of rare diseases…
-
Commercialising drugs in Europe: Lean models for first-time launchers
In 2025, 193 innovative drugs received approval in Europe, including 133 new molecular entities (NMEs). Over half – 56% -…
-
Lyophilisation is growing in pharma, but technical challenges persist
Lyophilisation, or freeze drying, is the process in which a liquid drug is converted into a stable powder via sublimation,…
-
China-ready by design: Leveraging NMPA’s new 30‑working day IND pathway
Over the last decade, China has become a key destination for oncology clinical trials, with Chinese sites increasingly incorporated within…
-
Why manual aseptic filling often provides faster start dates than automated lines
A Phase 1 start date may be tied to investor milestones. A rare disease therapy may represent a small patient…
-
Biomarkers in Nephrology Research: From Exploratory to Decision-Making Tools
While strategic use of biomarkers in clinical trials has traditionally been associated with oncology, the potential for growth across other…
-
Annex 1 sterilisation: Why pharma packaging strategy is changing
The revised EU GMP Annex 1 has ushered in a new phase for sterile manufacturing. Published in 2022, with most…
-
Early Biomarkers as Predictors of Nephrology Trial Trajectory
Chronic kidney disease (CKD) and other nephrology conditions are a major global health challenge. With rising prevalence and persistent unmet…